Zobrazeno 1 - 10
of 51
pro vyhledávání: '"R. Endele"'
Publikováno v:
European Journal of Clinical Pharmacology. 16:255-262
In Study I 20 normal volunteers received a single oral dose of spironolactone 100 mg. In Study II a further 20 normal volunteers were given first spironolactone 100 mg b.i.d. and subsequently spironolactone 100 mg once a day for a further 4 days. In
Autor:
G Lettenbauer, R Endele
Publikováno v:
Journal of Chromatography A. 115:228-231
Publikováno v:
International Journal of Mass Spectrometry and Ion Physics. 48:81-84
Two examples of quantitative drug concentration measurements in biological matrices are presented using (GC)-MS-MS techniques with a triple stage quadrupole mass spectrometer in the multiple reaction monitoring mode. Advantages over the well establis
Autor:
E. Besenfelder, R. Endele
Publikováno v:
Journal of High Resolution Chromatography. 4:419-421
Autor:
H. Kewitz, U. Sprandel, A. R. Hubbard, R. A. Chalmers, C. Piper, R. Bonn, E. Weber, R. Düsing, V. Nicolas, K. Glänzer, J. Kipnowski, H. J. Kramer, U. Abshagen, S. Spörl-Radun, G. Betzien, B. Kaufmann, R. Endele, J. Gellert, H. Frenzel, T. Heidenreich, M. Nishimura, R. Teschke, V. Schulz, A. Löffler, T. Pasch, G. Loeschcke, J. Busse, B. Kemmerich, H. Lode, G. Belmega, T. Jendroschek, K. Borner, P. Koeppe, G. Witkowski, G. Höffken, G. Dzwillo, J. Kuhlmann, G. Seidel, H. Grötsch, L. Münch, R. Fleischmann, R. Heinrich, H. Malchow, G. Bozler, H. R. Ochs, H. Otten, H. J. Kaschell, U. Klehr, W. Röllinghoff, R. Sticken, G. Paumgartner
Publikováno v:
Verhandlungen der Deutschen Gesellschaft für innere Medizin ISBN: 9783807003276
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3e88ae023808cd9b5d0c0f441a339187
https://doi.org/10.1007/978-3-642-47092-9_23
https://doi.org/10.1007/978-3-642-47092-9_23
Publikováno v:
Die Medizinische Welt. 32(14A)
Publikováno v:
Nitrattherapie heute ISBN: 9783528079321
Die Konzentrationsbestimmung von organischen Nitraten im Blut stellt hohe Anforderungen an die analytischen Methoden. Die zu erwartenden Serumkonzentrationen von Isosorbiddinitrat (ISDN), Isosorbid-2-mononitrat (IS-2-MN) und Isosorbid-5-mononitrat (I
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::49f4f09b2d987e5e0020b05444cf1153
https://doi.org/10.1007/978-3-322-87597-6_6
https://doi.org/10.1007/978-3-322-87597-6_6
Publikováno v:
European journal of clinical pharmacology. 20(4)
The pharmacokinetics of isosorbide-5-mononitrate (IS-5-MN) has been studied in two groups of healthy volunteers after oral (n = 20) and intravenous (n = 11) administration of 20 mg, which had previously been proved to be as effective as 20 mg sustain
Publikováno v:
European journal of clinical pharmacology. 27(6)
The bioavailabilities of a conventional and two slow release 20 mg isosorbide dinitrate (ISDN) formulations were compared after oral administration in a three way cross-over study in 8 male volunteers. In a further group of 6 male volunteers the phar
Publikováno v:
Journal of chromatography. 227(1)